An official website of the United States government
Number and rate* of newly reported cases† of chronic hepatitis C, by state or jurisdiction — United States, 2022
Source: CDC, National Notifiable Diseases Surveillance System.
* Rates per 100,000 population.
† Reported confirmed cases. For case definition, see Chronic Hepatitis C.
N: Not reportable. The disease or condition was not reportable by law, statue, or regulation in the reporting jurisdiction.
U: Unavailable. The data were unavailable.
This table displays the numbers and rates of newly reported chronic hepatitis C cases during 2022, by state or jurisdiction. Health departments might not have adequate resources for investigating all cases reported in their jurisdiction. During 2022, chronic hepatitis C was not a reportable condition in four states (Indiana, Kentucky, North Carolina, and Texas), and cases were unavailable from three states or jurisdictions (Arizona, California, and Hawaii). Of note, cases of newly reported chronic hepatitis C do not represent all prevalent hepatitis C virus (HCV) infections, which cannot be captured in the National Notifiable Diseases Surveillance System (NNDSS).
Of the 93,805 newly reported cases of chronic hepatitis C in 2022, the highest rate of newly reported cases of chronic hepatitis C was in Oklahoma (151.2 cases per 100,000 population), followed by West Virginia (131.6 cases per 100,000 population), Alabama (92.6 cases per 100,000 population), and Tennessee (81.7 cases per 100,000 population).
- Figure 3.1. Number of reported cases and estimated infections of acute hepatitis C — United States, 2015–2022
- Figure 3.2. Rates of reported cases of acute hepatitis C, by state or jurisdiction — United States, 2021–2022
- Figure 3.3. Rates of reported cases of acute hepatitis C, by state or jurisdiction — United States, 2022
- Figure 3.4. Rates of reported cases of acute hepatitis C, by age group — United States, 2007–2022
- Figure 3.5. Rates of reported cases of acute hepatitis C, by sex — United States, 2007–2022
- Figure 3.6. Rates of reported cases of acute hepatitis C, by race/ethnicity — United States, 2007–2022
- Figure 3.7. Availability of information on risk behaviors or exposures associated with reported cases of acute hepatitis C — United States, 2022
- Figure 3.8. Number of newly reported chronic hepatitis C cases by sex and age — United States, 2022
- Figure 3.9. Rates of deaths with hepatitis C listed as a cause of death among residents, by state or jurisdiction — United States, 2022
- Table 3.1. Numbers and rates of reported cases of acute hepatitis C, by state or jurisdiction — United States, 2018–2022
- Table 3.2. Numbers and rates of reported cases of acute hepatitis C, by demographic characteristics — United States, 2018–2022
- Table 3.3. Reported risk behaviors or exposures among reported cases of acute hepatitis C — United States, 2022
- Table 3.4. Number of newly reported cases of perinatal hepatitis C, by state or jurisdiction — United States, 2022
- Table 3.5. Number and rate of newly reported cases of chronic hepatitis C, by state or jurisdiction — United States, 2022
- Table 3.6. Number and rate of newly reported cases of chronic hepatitis C, by demographic characteristics — United States, 2022
- Table 3.7. Numbers and rates of deaths with hepatitis C listed as a cause of death among residents, by state or jurisdiction — United States, 2018–2022
- Table 3.8. Numbers and rates of deaths with hepatitis C listed as a cause of death among residents, by demographic characteristics — United States, 2018–2022